Concomitant versus sequential gemcitabine (G) and docetaxel (D) as first-line chemotherapy in advanced non-small-cell lung cancer (NSCLC):: updated outcomes and quality of life (QoL) results of a Phase II/III randomised study

被引：0
|
作者：
Thatcher, N
Manegold, C
Kortsik, C
Koschel, G
Spengler, W
Mezger, J
Müller, A
Pilz, LR
机构：
[1] Christie Hosp NHS Trust, Manchester M20 4BX, Lancs, England
[2] Univ Med Ctr, Mannheim, Germany
[3] KH Sankt Hildegardis, Catholic Clin Ctr Mainz, Mainz, Germany
[4] AKH Hamburg, Hamburg, Germany
[5] KH Schillerhohe, Gerlingen, Germany
[6] St Vincentius Kliniken, Med Klin, Karlsruhe, Germany
[7] Thoraxklin, Heidelberg, Germany
[8] German Canc Res Ctr, D-6900 Heidelberg, Germany
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：306 / 306
页数：1
相关论文
共 50 条
  • [21] Combination chemotherapy with carboplatin, docetaxel, and gemcitabine in advanced non-small-cell lung cancer: A phase II study
    Pectasides, D
    Aspropotamitis, A
    Halikia, A
    Visvikis, A
    Antoniou, F
    Kalantaridou, A
    Karvounis, N
    Batzios, S
    Athanassiou, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (12) : 3816 - 3821
  • [22] A phase II study of sequential docetaxel and gemcitabine followed by docetaxel and carboplatin as first-line therapy for non-small cell lung cancer
    Eleni M. Karapanagiotou
    Adrianni Charpidou
    Ifigenia Tzannou
    Kalliopi Dilana
    Elias Kotteas
    Ioannis Tourkantonis
    Epaminondas Kosmas
    Aspasia Provata
    Kostas Syrigos
    [J]. Medical Oncology, 2008, 25 : 303 - 308
  • [23] Phase I/II study of gemcitabine plus vinorelbine as first-line chemotherapy of non-small-cell lung cancer
    Lorusso, V
    Carpagnano, F
    Frasci, G
    Panza, N
    Di Rienzo, G
    Cisternino, ML
    Napoli, G
    Orlando, S
    Cinieri, S
    Brunetti, C
    Palazzo, S
    De Lena, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (02) : 405 - 411
  • [24] A phase II study of sequential docetaxel and gemcitabine followed by docetaxel and carboplatin as first-line therapy for non-small cell lung cancer
    Karapanagiotou, Eleni M.
    Charpidou, Adrianni
    Tzannou, Ifigenia
    Dilana, Kalliopi
    Kotteas, Elias
    Tourkantonis, Ioannis
    Kosmas, Epaminondas
    Provata, Aspasia
    Syrigos, Kostas
    [J]. MEDICAL ONCOLOGY, 2008, 25 (03) : 303 - 308
  • [25] A PHASE II TRIAL OF WEEKLY DOCETAXEL COMBINED WITH CARBOPLATIN AS FIRST-LINE CHEMOTHERAPY FOR ADVANCED NON-SMALL-CELL LUNG CANCER
    Nong, X.
    Zhang, X.
    Xiong, J.
    Fang, W.
    Zhang, L.
    Zhong, L.
    Chen, J.
    Yu, F.
    Qian, J.
    Deng, J.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 157 - 157
  • [26] Phase I/II study of paclitaxel, gemcitabine and vinorelbine as first-line chemotherapy of non-small-cell lung cancer
    Lorusso, V
    Crucitta, E
    Panza, N
    Silvestris, N
    Guida, M
    Carpagnano, F
    Mancarella, S
    Sambiasi, D
    De Lena, M
    [J]. ANNALS OF ONCOLOGY, 2002, 13 (12) : 1862 - 1867
  • [27] First-line treatment of advanced non-small-cell lung cancer with docetaxel and cisplatin: A multicenter phase II study
    Georgoulias, V
    Androulakis, N
    Dimopoulos, AM
    Kourousis, C
    Kakolyris, S
    Papadakis, E
    Apostolopoulou, F
    Papadimitriou, C
    Vossos, A
    Agelidou, M
    Heras, P
    Tzannes, S
    Vlachonicolis, J
    Mavromanolakis, E
    Hatzidaki, D
    [J]. ANNALS OF ONCOLOGY, 1998, 9 (03) : 331 - 334
  • [28] Biweekly docetaxel and gemcitabine as first line chemotherapy in advanced non-small cell lung cancer (NSCLC)
    Gaspar, E.
    Firvida, J.
    Amenedo, M.
    Orts, D.
    Salgado, M.
    LLorca, C.
    Ramos, M.
    Perez, E.
    Cervera, J.
    Abal, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [29] First-line gemcitabine with cisplatin or epirubicin in advanced non-small-cell lung cancer: a phase III trial
    Wachters, FM
    van Putten, JWG
    Kramer, H
    Erjavec, Z
    Eppinga, P
    Strijbos, JH
    de Leede, GPJ
    Boezen, HM
    de Vries, EGE
    Groen, HJM
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 (07) : 1192 - 1199
  • [30] First-line gemcitabine with cisplatin or epirubicin in advanced non-small-cell lung cancer: a phase III trial
    F M Wachters
    J W G van Putten
    H Kramer
    Z Erjavec
    P Eppinga
    J H Strijbos
    G P J de Leede
    H M Boezen
    E G E de Vries
    H J M Groen
    [J]. British Journal of Cancer, 2003, 89 : 1192 - 1199
12345